NCCAM/ODS fact sheets
This article was originally published in The Tan Sheet
Executive Summary
Information on topics such as selecting a CAM practitioner and "consumer financial issues" will be addressed in a series of 1fact sheets appearing on NCCAM's web site this fall; two already have been posted. Ingredient-specific information on black cohosh and menopause, valerian and sleep disorders, as well as a "general backgrounder on botanicals" is being co-produced with NIH Office of Dietary Supplements, and also will be featured on ODS's site. Each sheet is written and reviewed by experts in pharmocognosy and office and center staff...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.